National University Hospital (NUH)
Singapore, Singapore
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche152 enrolled93 locationsNCT05503264
Recruiting
Phase 2
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Ovarian Cancer
ARCAGY/ GINECO GROUP390 enrolled88 locationsNCT05183984
Recruiting
Phase 1Phase 2
Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma (RRMM)
YOUNGIL KOH75 enrolled7 locationsNCT06645678